Hamdy M Abdel-Rahman

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Papillary Thyroid

Molecular Docking

Small Cell Lung Cancer

Oxide Nanoparticles

Top Venues

Molecules (Basel, Switzerland)

Drug design, development and therapy

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Bahaa G M Youssif, Martha M Morcoss, Stefan Bräse, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, Dalal A Abou El-Ella, El Shimaa M N Abdelhafez
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies. Molecules (Basel, Switzerland) 29 (2) (2024)
Bahaa G M Youssif, Martha M Morcoss, Stefan Bräse, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, Dalal A Abou El-Ella, El Shimaa M N Abdelhafez
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies. Molecules (Basel, Switzerland) 29 (2) (2024)
Bahaa G M Youssif, Martha M Morcoss, Stefan Bräse, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, Dalal A Abou El-Ella, El Shimaa M N Abdelhafez
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies. Molecules (Basel, Switzerland) 29 (2) (2024)
Bahaa G M Youssif, Martha M Morcoss, Stefan Bräse, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, Dalal A Abou El-Ella, El Shimaa M N Abdelhafez
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies. Molecules (Basel, Switzerland) 29 (2) (2024)
Mostafa A Mansour, Asmaa M AboulMagd, Samar H Abbas, Hamdy M Abdel-Rahman, Mohamed Abdel-Aziz
Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review. RSC advances 13 (27) (2023)
Mohamed A S Badawy, Eman K A Abdelall, El-Shaymaa El-Nahass, Khaled R A Abdellatif, Hamdy M Abdel-Rahman
Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4-(methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors. RSC advances 11 (44) (2021)
Rehab H Abd El-Aleam, Riham F George, Hanan H Georgey, Hamdy M Abdel-Rahman
Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance. RSC advances 11 (58) (2021)
Ibrahim A Darwish, Nasr Y Khalil, Nawaf A Alsaif, Rashed N Herqash, Ahmed Y A Sayed, Hamdy M Abdel-Rahman
Charge-Transfer Complex of Linifanib with 2,3-dichloro-3,5-dicyano-1,4-benzoquinone: Synthesis, Spectroscopic Characterization, Computational Molecular Modelling and Application in the Development of Novel 96-microwell Spectrophotometric Assay. Drug design, development and therapy 15 (2021)
Hend A A Abd El-Wahab, Ahmed M Ali, Hamdy M Abdel-Rahman, Wesam S Qayed
Synthesis, biological evaluation, and molecular modeling studies of acetophenones-tethered 1,2,4-triazoles and their oximes as epidermal growth factor receptor inhibitors. Chemical biology & drug design (2021)
Mostafa A Mansour, Asmaa M AboulMagd, Hamdy M Abdel-Rahman
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins. RSC advances 10 (56) (2020)